Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Cerilliant
McKinsey
Farmers Insurance
Covington
Medtronic
Cipla
Moodys
US Department of Justice

Generated: February 22, 2018

DrugPatentWatch Database Preview

MELLARIL Drug Profile

« Back to Dashboard

When do Mellaril patents expire, and when can generic versions of Mellaril launch?

Mellaril is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in MELLARIL is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
Drug patent expirations by year for MELLARIL
Medical Subject Heading (MeSH) Categories for MELLARIL

US Patents and Regulatory Information for MELLARIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis MELLARIL thioridazine hydrochloride CONCENTRATE;ORAL 011808-012 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-009 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-016 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-017 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride CONCENTRATE;ORAL 011808-018 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-011 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL-S thioridazine SUSPENSION;ORAL 017923-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL-S thioridazine SUSPENSION;ORAL 017923-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Johnson and Johnson
Medtronic
Argus Health
Cipla
Julphar
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot